At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 23, 2026 at 06:07 ET
Medline Inc. filed a definitive proxy statement for its 2026 Annual Meeting, where shareholders will vote on director elections, executive compensation approval, and auditor ratification. The filing is routine and does not contain material financial disclosures.
- Annual meeting scheduled for June 11, 2026
- Shareholders will vote on 12 director nominees
- Advisory vote on executive compensation and auditor ratification included
- No new financial information or material changes disclosed
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access